Ratings Healthcare Services Group, Inc.

Equities

HCSG

US4219061086

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
10.78 ^USD	+0.47%		-0.19%	+3.95%

Apr. 30	Orpea's Emeis Sells Dutch Nursing Home Portfolio in EUR97 Million Deal	MT
Apr. 24	Transcript : Healthcare Services Group, Inc., Q1 2024 Earnings Call, Apr 24, 2024

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.39 for the 2024 fiscal year.
For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Historically, the company has been releasing figures that are above expectations.

Weaknesses

According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
The company sustains low margins.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Business Support Services

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
HEALTHCARE SERVICES GROUP, INC.	+3.95%	794M		C
GDI INTEGRATED FACILITY SERVICES INC.	-12.17%	553M		C-
MEARS GROUP PLC	+27.10%	492M		B-
SHENGHUI CLEANNESS GROUP HOLDINGS LIMITED	-27.03%	56.1M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes